AI Assistant
Blog
Pricing
Log In
Sign Up
Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
